ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2003

Chondrocyte Size in Articular Cartilage As a Marker of Osteoarthritis Severity

Paula Gratal1, Aranzazu Mediero2, Iván Prieto-Potin1, Ana Lamuedra1, Gabriel Herrero-Beaumont1 and Raquel Largo1, 1Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain, 2Joint and Bone Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: chondrocytes, osteoarthritis and severity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Terminal differentiating growth plate chondrocytes are mainly characterized by an increase of their cell size and by the expression of hypertrophic markers such as type X Collagen. Likely, during osteoarthritis (OA) progression, articular chondrocytes acquire a similar protein profile, and, therefore, they have been commonly described as hypertrophic-like chondrocytes. Our aim was to study whether an increase in chondrocyte size may be a feature of the hypertrophic-like phenotype in the articular cartilage (AC) of experimental OA rabbits and in OA human cartilage. The anatomical location of these bigger cells in the deeper zones was also assessed.

Methods:

New Zealand female rabbits were randomly assigned to four groups: healthy (n=8), osteoporosis (OP, n=7), OA (n=8) and OA preceded by OP (OPOA, n=8). OP was induced by ovariectomy followed by metilprednisolone administration (1mg/kg/day) during four weeks. OA was induced by anterior cruciate ligament section and partial medial meniscectomy, lasting over a period of 6 weeks. All animals were euthanized and tibias were collected for histological analysis. Cartilage damage and chondrocyte size were assessed in Safranin-O fast green stained sections. Type X Collagen presence was analyzed by immunohistochemistry. Nine human samples were obtained during total knee replacement surgery to perform identical histological studies after the informed consent was gained. Statistical comparisons were performed using Kruskal-Wallis and Mann Whitney tests, whereas correlations were done with Spearman test.

Results:

Mankin score showed an increase in cartilage damage in all groups in comparison to healthy rabbits. The most severe cartilage damage was observed in the OPOA group (Healthy: 1.0 (0-1.5), OP: 2.3 (1.5-4.5), OA: 8.0 (7-13), OPOA: 13 (11-16)). Chondrocyte size in OA and OPOA cartilages were greater than that in healthy cartilage, and significantly greater in OPOA vs OA (Healthy: 133.0 (91.1-158.7), OP: 140.7 (119.7-198.3), OA: 180.9 (120.5-266.4), OPOA: 217.4 (183.6-303.5). However, no differences in the mean chondrocyte size were found between the deepest and in the most superficial regions of the AC in any of the groups analyzed. Chondrocyte size and cartilage damage were significantly and positively correlated (p<0.001, r=0.718). In addition, chondrocyte size was also associated with immunoreactive type X Collagen staining (p<0.05, r=0.444). Regarding human OA cartilage, chondrocyte size also correlated with cartilage damage and with type X Collagen presence (p<0.001, r=0.921 and p<0.05, r=0.663 respectively).

Conclusion: We observed an increase of the chondrocyte size in OA cartilage in relation to an increased cartilage damage. These bigger chondrocytes were homogeneously distributed in the deepest and in the most superficial regions of the AC. A positive correlation was also found between the chondrocyte size and the presence of type X Collagen, both in human and experimental OA cartilage. Our results suggest that chondrocyte size could be a reliable hypertrophic marker of the OA articular cartilage.


Disclosure: P. Gratal, None; A. Mediero, CP15/00053 PI16/0991, 2, 9; I. Prieto-Potin, None; A. Lamuedra, None; G. Herrero-Beaumont, None; R. Largo, None.

To cite this abstract in AMA style:

Gratal P, Mediero A, Prieto-Potin I, Lamuedra A, Herrero-Beaumont G, Largo R. Chondrocyte Size in Articular Cartilage As a Marker of Osteoarthritis Severity [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/chondrocyte-size-in-articular-cartilage-as-a-marker-of-osteoarthritis-severity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chondrocyte-size-in-articular-cartilage-as-a-marker-of-osteoarthritis-severity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology